Dean Capital Investments Management LLC Has $384,000 Position in Waters Co. (WAT)

Dean Capital Investments Management LLC reduced its position in shares of Waters Co. (NYSE:WAT) by 25.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,974 shares of the medical instruments supplier’s stock after selling 658 shares during the period. Dean Capital Investments Management LLC’s holdings in Waters were worth $384,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Fort L.P. bought a new position in shares of Waters in the second quarter worth about $118,000. Cornerstone Advisors Inc. raised its stake in shares of Waters by 1,651.2% in the second quarter. Cornerstone Advisors Inc. now owns 753 shares of the medical instruments supplier’s stock worth $146,000 after acquiring an additional 710 shares during the last quarter. Checchi Capital Advisers LLC bought a new position in shares of Waters in the third quarter worth about $201,000. First Hawaiian Bank bought a new position in shares of Waters in the third quarter worth about $208,000. Finally, Mission Wealth Management LP bought a new position in shares of Waters in the third quarter worth about $208,000. 99.26% of the stock is owned by hedge funds and other institutional investors.

WAT has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Waters from a “sell” rating to a “hold” rating in a research note on Thursday, August 23rd. Barclays lowered their price target on shares of Waters from $200.00 to $190.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 24th. Leerink Swann cut shares of Waters from an “outperform” rating to a “market perform” rating in a research report on Monday, October 8th. JPMorgan Chase & Co. lowered their price target on shares of Waters from $200.00 to $185.00 and set a “neutral” rating for the company in a research report on Wednesday, October 24th. Finally, Cleveland Research upgraded shares of Waters from a “sell” rating to a “neutral” rating in a research report on Thursday, October 11th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company. Waters has an average rating of “Hold” and a consensus price target of $206.86.

Shares of NYSE:WAT opened at $196.66 on Friday. Waters Co. has a one year low of $167.93 and a one year high of $220.20. The company has a quick ratio of 5.93, a current ratio of 6.63 and a debt-to-equity ratio of 0.61. The company has a market cap of $14.83 billion, a PE ratio of 26.26, a price-to-earnings-growth ratio of 2.34 and a beta of 0.94.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 EPS for the quarter, topping the consensus estimate of $1.90 by $0.02. Waters had a net margin of 2.32% and a return on equity of 30.68%. The company had revenue of $578.02 million during the quarter, compared to analysts’ expectations of $587.43 million. During the same quarter in the previous year, the company earned $1.77 EPS. Waters’s revenue was up 2.2% on a year-over-year basis. As a group, equities research analysts forecast that Waters Co. will post 8.05 earnings per share for the current fiscal year.

In related news, Director Christopher A. Kuebler sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $199.67, for a total transaction of $1,597,360.00. Following the completion of the transaction, the director now owns 18,911 shares in the company, valued at $3,775,959.37. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 3,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $192.00, for a total transaction of $672,000.00. Following the transaction, the director now owns 20,911 shares of the company’s stock, valued at approximately $4,014,912. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,500 shares of company stock valued at $3,031,840. Corporate insiders own 0.98% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Dean Capital Investments Management LLC Has $384,000 Position in Waters Co. (WAT)” was first posted by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.wkrb13.com/2018/11/25/dean-capital-investments-management-llc-has-384000-position-in-waters-co-wat.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More: What is cost of equity?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply